|Slideshows|May 12, 2014

Meet the Microbes

From Acinetobacter to VRE, here's a look at some bad bugs and how to eradicate them in the healthcare setting.

Newsletter

Stay prepared and protected with the Infection Control Today newsletter, delivering essential updates, best practices, and expert insights for infection prevention professionals.

Subscribe

Related Content

Health care workers in Uganda (Image credit by author with AI)

The Discipline of Waiting: Uganda's 42-Day Ebola Countdown

ByBrenna Doran, PhD, MA, ACC, CIC, AL-CIP

July 23rd 2026

Sepsis concept represented by wooden letter tiles on a wooden table with glasses and a book (Adobe Stock 328579157by lexiconimages)

Beyond the Alert: Why Sepsis Outcomes Come Down to What Happens After Detection

ByKaren Biesack, RHIA, CPHQ, CPPS

July 23rd 2026

Patients in Cambodia. (Image by Brayden Unger via AI)

Special Feature. Three Days in Cambodia: What a Volunteer Saw Before He Had the Words

ByBrenna Doran, PhD, MA, ACC, CIC, AL-CIP,Brayden Unger

July 22nd 2026

Hepatitis C written on a page. (Adobe Stock 112538011 by Vitalii Vodolazskyi)

Atea Completes Enrollment in Phase 3 Hepatitis C Trial Evaluating Bemnifosbuvir and Ruzasvir

ByInfection Control Today® Editorial Staff

July 21st 2026

Contagious Conversations: Global Infection Prevention Leaders Say the Future of IPC Depends on Diverse Career Pathways

ByTori Whitacre Martonicz, MA

July 21st 2026

Latest CME

Video

A Shield of Protection: Unmet Needs in COVID-19 Prevention and Control

Onyema Ogbuagu, MD, FACP, FIDSA; Jeffery A. Goad, PharmD, MPH; William P. Hanage, PhD

Multimedia

Empowering HIV Management: Evidence-Based Prevention and Treatment Strategies

Onyema Ogbuagu, MD, FACP, FIDSA

Meet the Microbes

Related Content

The Discipline of Waiting: Uganda's 42-Day Ebola Countdown

Beyond the Alert: Why Sepsis Outcomes Come Down to What Happens After Detection

Special Feature. Three Days in Cambodia: What a Volunteer Saw Before He Had the Words

Atea Completes Enrollment in Phase 3 Hepatitis C Trial Evaluating Bemnifosbuvir and Ruzasvir

Contagious Conversations: Global Infection Prevention Leaders Say the Future of IPC Depends on Diverse Career Pathways

Latest CME

A Shield of Protection: Unmet Needs in COVID-19 Prevention and Control

Empowering HIV Management: Evidence-Based Prevention and Treatment Strategies

Trending on Infection Control Today

The Discipline of Waiting: Uganda's 42-Day Ebola Countdown

Beyond the Alert: Why Sepsis Outcomes Come Down to What Happens After Detection

FDA Says False-Positive Test Does Not Change Cyclospora Outbreak Investigation

Contagious Conversations: Global Infection Prevention Leaders Say the Future of IPC Depends on Diverse Career Pathways

Special Feature. Three Days in Cambodia: What a Volunteer Saw Before He Had the Words